About Hermes Bioscience
Hermes Bioscience is a company founded in 2024. It operates as a B2B and Direct Sales. Hermes Bioscience offers products and services including Exosome Isolation System and Extracellular Vesicle App. Hermes Bioscience operates in a competitive market with competitors including Exosome Plus, Exostatics and Exom Biopharma, among others.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hermes Bioscience
Hermes Bioscience offers a comprehensive portfolio of products and services, including Exosome Isolation System and Extracellular Vesicle App.
Benchtop system for quick, efficient exosome purification from fluids.
Hands-off tool for processing and analyzing cell culture media.
Funding Insights of Hermes Bioscience
Detailed funding history for Hermes Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hermes Bioscience
Investment portfolio details for Hermes Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hermes Bioscience
Detailed financials for Hermes Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hermes Bioscience Comparisons
Peer comparison for Hermes Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hermes Bioscience
Hermes Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exosome Plus, Exostatics and Exom Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of reagents for detection and quantification of exosome
|
|
| Locked | Locked | Locked |
Develops unbiased exosome binding technology for medical diagnostics and treatments.
|
|
| Locked | Locked | Locked |
Provides comprehensive exosome-based solutions for gene and drug delivery.
|
Detailed competitors of Hermes Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hermes Bioscience
Complete news archive for Hermes Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hermes Bioscience
Hermes Bioscience was founded in 2024.
Hermes Biosciences develops a hands-off extracellular vesicle isolation system that processes bodily fluids and cell culture media to purify exosomes quickly and reproducibly. It targets researchers in fields like oncology, degenerative diseases, and regenerative medicine. The system enhances understanding of exosome functions for clinical use. Founded by experts from Stanford University School of Medicine, it operates in the USA, focusing on innovative biotechnology solutions for scientific advancement.
Hermes Bioscience's top competitors include Exosome Plus, Exostatics and Exom Biopharma.
Hermes Bioscience offers Exosome Isolation System and Extracellular Vesicle App.